Article Details
Retrieved on: 2022-11-20 08:15:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Neo Ivy Capital Management now owns 8,631 shares of the biopharmaceutical company's stock valued at $186,000 after buying an additional 6,810 shares ...
Article found on: reporter.am
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here